首页 | 本学科首页   官方微博 | 高级检索  
检索        


4-Week repeated dose oral toxicity study of N-ethyl-2-pyrrolidone in Sprague Dawley rats
Institution:1. Department of Psychology, University of Connecticut, Storrs, CT, USA;2. Department of Anatomy and Pathology, School of Medical Sciences, University of Adelaide, Adelaide, Australia;3. Area of Psychobiology, University Jaume I, Castelló, Spain
Abstract:The solvent N-ethyl-2-pyrrolidone (NEP) was evaluated in a 4-week repeated dose study in rats. NEP diluted in distilled water was orally administered by gavage to male and female Sprague-Dawley rats at doses of 0 (vehicle control), 5, 50, and 250 mg/kg/day for 28 consecutive days. Transient decreases in the body weight and in the body weight gain of the males was observed during the first days of treatment at the 50 and 250 mg/kg/day doses. There was a marked increase in urine volume at the beginning of treatment in males and female rats at doses of 50 and 250 mg/kg/day. No biologically significant differences were observed in hematological and clinical chemistry values in males and females at necropsy. Histological examination revealed an increase in hyaline droplets in the renal tubules of the kidneys and hepatocellular centrilobular hypertrophy in the liver of males at 250 mg/kg/day. Cytochrome P450 concentration in liver microsomes was slightly increased at 250 mg/kg/day in males. The results of this study demonstrate that NEP has mild to no effects at doses up to 250 mg/kg/day when administered orally to rats for 28 days with males being more susceptible than females.
Keywords:Rat  28-Day study  Toxicity  CYP 450"}  {"#name":"keyword"  "$":{"id":"kwrd0035"}  "$$":[{"#name":"text"  "_":"cytochrome P450  CYP 2E1"}  {"#name":"keyword"  "$":{"id":"kwrd0045"}  "$$":[{"#name":"text"  "_":"cytochrome P450 2E1  GGT"}  {"#name":"keyword"  "$":{"id":"kwrd0055"}  "$$":[{"#name":"text"  "_":"gamma glutamyl transferase  NEP"}  {"#name":"keyword"  "$":{"id":"kwrd0065"}  "$$":[{"#name":"text"  "$$":[{"#name":"italic"  "_":"N"}  {"#name":"__text__"  "_":"-ethyl-2-pyrrolidone  NAG"}  {"#name":"keyword"  "$":{"id":"kwrd0075"}  "$$":[{"#name":"text"  "_":"N-acetyl glucosaminidase  LOAEL"}  {"#name":"keyword"  "$":{"id":"kwrd0085"}  "$$":[{"#name":"text"  "_":"lowest-observed-adverse-effect-level  NMP"}  {"#name":"keyword"  "$":{"id":"kwrd0095"}  "$$":[{"#name":"text"  "$$":[{"#name":"italic"  "_":"N"}  {"#name":"__text__"  "_":"-methyl-2-pyrrolidone  NOAEL"}  {"#name":"keyword"  "$":{"id":"kwrd0105"}  "$$":[{"#name":"text"  "_":"no-observed-adverse-effect-level  NOEL"}  {"#name":"keyword"  "$":{"id":"kwrd0115"}  "$$":[{"#name":"text"  "_":"No-effect-level
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号